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Structural Insights into Modulation of Mical by its Calponin Homology
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Saif S. Alqassim, Mario A. Bianchet, L. Mario Amzel.
Johns Hopkins University - School of Medicine, Baltimore, MD, USA.
MICAL (Molecule Interacting with CasL) is a 1048 amino acid protein
consisting of a monooxygenase domain (FD) with redox activity, a Calponin
homology domain (CH), a LIM domain, a proline-rich region, and a C-term re-
gion containing coiled-coil ERM a-like domain. In axon guidance, MICAL is a
key molecule that links the extracellular signal from semaphorins -a class of
repulsive guidance cues- to the reorganization of the cytoskeleton. Proper
axon guidance, the process by which growing axons respond to extracellular
cues that guide them towards their appropriate targets, is vital in neural devel-
opment processes such as neuronal cell-migration, axonal branching, path
finding, and fasiculation/defasiculation. Our laboratory has previously deter-
mined the crystal structure of MICALs FD domain (MICALFD) and showed
that it uses NADPH as the reductant. Studies showed that MICALFD and
MICALFD-CH can bind and oxidize Met44 on actin filaments, thereby affecting
their polymerization dynamics. However, modulation of these MICAL activ-
ities by its non-redox domains is poorly understood. To structurally charac-
terize the modulation by the CH domain, we determined the crystal structure
of MICALFD-CH to 3.0-A˚ resolution. The structure reveals that the CH domain
does not interact with the active site in the FD domain. Furthermore, the FD and
CH domains are flexible with respect to each other; MICALFD-CH crystallized
in two different crystal forms, and no electron density was observed for the
18-residue linker between the two domains. In actin-binding proteins with tan-
dem CH domains, the flexibility of the domains with respect to each other is
important for binding F-actin. Similarly, the flexibility of the two domains in
MICALFD-CH may be important in optimizing the binding to F-actin such
that Met44 is more accessible to the active site.
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Membrane proteins have a variety of functions in the cell, which are important
from both biological and therapeutic standpoints. However, structure determi-
nation of membrane proteins is still challenging due to their hydrophobic na-
ture. Techniques such as chaperone-based crystallization, tailoring the lipid
and/or detergent environment and mutagenesis studies have emerged to make
crystallization of a target membrane protein tractable. However, most of those
techniques are specific to target protein; a more general approach would be
beneficial. Our potentially generalizable approach uses engineered single chain
antibody fragments (scFvs) specific to a short peptide epitope that can be
inserted into any extramembranous loop of target membrane protein. Tight
binding of engineered scFv variants to the membrane protein will provide a
more hydrophilic crystal contacts leading to more stable crystal lattices, and
better diffracting crystals.
A toolbox of such scFv ‘crystallization chaperones’ is being developed based
on the scaffold of anti-His6 3D5, which employs non-CDR residues in crystal
contacts and has a ~75A˚ channel in its crystal lattice. We used protein engineer-
ing techniques to improve biophysical characteristics of the parent scFv and to
alter the binding specificity to the EE epitope ("EYMPME"). Here we present
our first- and second-generation crystallization chaperones, as well as progress
toward complexation and co-crystallization with both a-helical and b-barrel
membrane proteins.
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Structural biology of membrane proteins (MP) is hampered by the difficulty to
produce and purify them in milligrams amount required for biophysical studies.
In bacteria, over expression of MP results in the formation of inclusion bodies
or to poor accumulation in bacterial membranes, often associated with cell
toxicity. Despite these difficulties, bacterial systems are heavily used and still
under development. The T7 RNA polymerase based expression system has
evolved to cover a wide windows of strength and regulation as exemplified
by the selection of T7 bacterial mutant hosts C41(DE3) and C43(DE3). In order
to assess the impact of these mutants in structural biology, we have conductedan extensive analysis of the protein data bases. Among the 1219 PDB codes
linked to MP structures (386 unique MP), 410 of them (140 unique MP)
referred to the heterologous production of membrane proteins in Escherichia
coli. Analysis of the corresponding publications revealed that the T7 based
expression system was used in the most of the cases (68%) followed by the
T5 and arabinose based expression systems (14% and 11% respectively).
The C41(DE3) and C43(DE3) bacterial hosts have contributed to 22% of the
total amount of MP structures (31 unique MP structures) and to 50% of heter-
ologous integral membrane proteins produced in the T7 based expression sys-
tem. Given the impact of those mutants in structural biology, we systematically
recovered the expression protocols of all publications citing Moffatt and
Studier (1986) or Miroux and Walker !1996) for the uses of BL21(DE3) or
C41/C43(DE3) respectively. Using pattern matching regular expressions, up
to 3000 articles were analysed for expression conditions (bacterial host-
vector, temperature, induction, companion plasmids). By doing this, we have
established a set of emerging rules for an optimal use of these expression
systems.
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DNA topoisomerases are molecular machines that are crucial for cell survival,
as they are capable of relaxing or introducing DNA supercoils to prevent topo-
logical problems resulting frommany different cellular processes, such as repli-
cation or transcription. The focus of my research is DNA gyrase, a type IIA
topoisomerase, which can be targeted by various antibiotics that bind to either
the DNA cleavage site or the ATPase domain. The structures of individual
domains from this heterotetrameric protein have been determined and studies
detailing parts of the complex reaction mechanism involving a concerted dou-
ble stranded DNA break followed by strand passage and resealing of the
cleaved DNA have been conducted. The mechanism of action of gyrase is
similar to other topoisomerases; however, it is unique among type II topoiso-
merases in its ability to introduce negative supercoils into DNA in a reaction
coupled to ATP hydrolysis. This feature is mediated by the C terminal domain
of the two GyrA subunits, which are absent in other members of this family.
The aim of my research is to probe the mechanism of action of gyrase through
structural studies. One aspect of the project is to solve a high resolution struc-
ture of the complex using X-ray crystallography. Another aspect of this project
is to determine the structures of the enzyme trapped in various catalytic states
utilizing a variety of inhibitors, cofactors, and enzyme mutants using both
X-ray crystallography and electron microscopy. These structures will help
verify or refute currently accepted gyrase complex models. Solving these struc-
tures will advance the understanding of how type II topoisomerases perform
their physiological role.
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The relative levels of plasma cholesterol in different lipoproteins are the major
indicator for CVD and related diseases. Nascent discoidal HDL particles,
which are then converted to spherical mature HDL by lecithin-cholesterol
acyltransferase (LCAT), are integral in reverse cholesterol transport. Detailed
knowledge of HDL structure is key to understanding its molecular mecha-
nisms, including how Paraoxynase 1 (PON1) associates with the phospholipid
surface of HDL helping prevent oxidation. Despite public interest in HDL
structure related function, their highly dynamic nature has prevented precise
structural determinations for nearly half a century. Here, we used our recently
developed individual particle electron tomography (IPET) technique to study
each individual complex of HDL-LCAT. The 3D reconstructions show, i)
LCAT associates with HDL along a proposed mobile region of the apoA-1
backbone (res ~122-142), where both monomers overlap antiparallel along
the discoidal edge of HDL; ii) PON1 interacts with HDL through its hydropho-
bic tail, which binds into the phospholipid surface, and loosely associates with
apoA-1. The structure provides novel information for modeling nascent discoi-
dal HDL and further reveals the first view of HDL structural dynamics in three-
dimensions. This result will benefit public knowledge and pharmaceutical drug
design to control plasma HDL cholesterol level.
